Understanding how mRNA modifications regulate gene expression
Uncovering the regulatory principles of dynamic mRNA methylation
This study is looking at how certain chemical changes in a type of genetic material called mRNA can affect how our genes work, which could help us understand diseases like cancer and brain disorders better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10885954 on NIH RePORTER |
What this research studies
This research investigates the role of chemical modifications in mRNA, which are crucial for regulating gene expression, RNA processing, and stability. By utilizing advanced high-throughput sequencing methods, the project aims to uncover the mechanisms behind these modifications, particularly focusing on a newly identified modification called N1-methyladenosine (m1A). The research will explore how these modifications function and are regulated, moving beyond the previously studied N6-methyladenosine (m6A) to provide a more comprehensive understanding of mRNA biology. This could lead to insights into various diseases, including cancers and neurodegenerative disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with cancers or degenerative neurologic disorders that may be influenced by mRNA regulation.
Not a fit: Patients with conditions unrelated to mRNA modifications or gene expression regulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for diseases linked to mRNA regulation, improving patient outcomes.
How similar studies have performed: While the study of mRNA modifications is a growing field, the specific focus on N1-methyladenosine (m1A) is relatively novel and has not been extensively tested in prior research.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Nachtergaele, Sigrid H — Yale University
- Study coordinator: Nachtergaele, Sigrid H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.